Navigation Links
Unilife Corporation Announces Financial Results For Fiscal Year 2012 Fourth Quarter
Date:7/30/2012

YORK, Pa., July 30, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced financial results for the quarter ended June 30, 2012, (the fourth quarter of Fiscal Year 2012).

Unilife CEO, Alan Shortall stated, "We are pleased to have delivered on our key business milestones set out for the past twelve months, and remain on schedule to continue this consistent trend in the current fiscal year. I believe we are at a key inflection point in our growth. We have established a large and growing base of pharmaceutical companies who are seeking access to the Unifill® syringe and our other proprietary devices in order to generate brand differentiation and optimize revenues for their brand name, generic and biosimilar drugs. We look forward to the formalization of a series of long-term commercial partnerships moving forward."

Unifill Prefilled SyringeMr. Shortall continued, "During the last quarter, we began to enter into commercial supply contracts with pharmaceutical customers for the Unifill syringe. New and recurring shipments of small batches of the Unifill syringe are now being made to a number of pharmaceutical customers on a regular basis. It has been indicated to us that some of these customers are now at various stages in the evaluation, stability study and fill-finish validation of our device. Several customers have reported to us that they are targeting the Unifill syringe for use with several of their approved and late-stage pipeline molecules. It has also been confirmed that the initial supply of the Unifill to other new global pharmaceutical customers will commence over the coming months."

AutoInfusor Devices of Disposable Subcutaneous Delivery Systems "Our AutoInfusor™ devices are generating market activity with a number of global pharmaceutical companies for the delivery of large dos
'/>"/>

SOURCE Unilife Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
2. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
3. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
6. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
7. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
8. Luminex Corporation Reports First Quarter 2012 Results
9. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
10. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
11. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board of ... announced that Tamas Feitel has joined the ... Numotion after a highly successful 18 year career at ... driving strategy, profitability, and productivity to result in significant ... position was Chief Financial Officer for GE Healthcare Global ...
(Date:7/2/2015)... 2, 2015   Decision Resources Group ... identify less frequent dosing as the highest unmet ... the burden on both patients and providers associated ... (VEGF) injections, which are the current standard of ... which is in development for dosing every two ...
(Date:7/2/2015)... , July 2, 2015 ... (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes ... and Forecast to 2020", Silage Inoculants & Enzymes Market ... a CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... Sept. 1 There has been recent,concern that ... Montelukast is a Food and Drug Administration (FDA) ... than a decade for the treatment of,asthma and ... the,American Lung Association has found no evidence of ...
... CMS, Inc., an Elekta Company and,worldwide ... management,solutions, today announced that three sites have ... Modulated,Radiotherapy (IMRT) treatment planning system. Allegheny General ... Rotterdam,Netherlands, and Froedtert Memorial Lutheran Hospital in ...
Cached Medicine Technology:American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast 2American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast 3CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System 2
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... on July 2nd creating a buzz of media attention. In an effort to ... by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed by ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... 2015 Annual Conference , the premiere continuing education and networking event ... at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts in ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, the 2016 ... the Westin Galleria Dallas. , Designed to take participants from the basic training and ...
(Date:7/3/2015)... Lenexa, KS (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... Okla. One of the top-ranked executive search firms in the healthcare industry, B. ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... smoking the first cigarette in the morning, the more difficult ... Yale School of Medicine study in Drug and Alcohol Dependence. ... found significant reductions in craving, withdrawal and mood after smoking ... reduction, the more likely the smoker would relapse, said Benjamin ...
... patients of the superbug MRSA - by treating their foot ... his team used green bottle fly larvae to treat 13 ... found all but one were cured within a mean period ... the conventional treatment. ,Professor Boulton, who published the ...
... developing a brain disease similar to mad cow disease, according ... Academy of Neurology's 59th Annual Meeting in Boston, April 28 ... cow disease, and chronic wasting disease, are fatal and there ... when an animal eats the body parts of other animals ...
... made headway in the development of an investigative blood ... to develop complications in the bone marrow, leading to ... Brisbane's Mater Medical Research Institute (MMRI) and Sydney's West ... a simple blood test to detect such tendencies. ...
... companies is not happy with the proposal to fortify all ... the state and federal governments to veto this proposal. ... enhance the foliate levels in women of child-bearing age. The ... spina bifida. ,If you ask Ian Greenshields from ...
... both get high blood pressure and related kidney disease, the path ... men , researchers say. ,They may end up ... could be very different, says Dr. Jennifer C. Sullivan, pharmacologist/physiologist ... ,Its known that men tend to develop hypertension earlier ...
Cached Medicine News:Health News:Reduction in Nicotine Craving Predicts Ability to Quit 2Health News:Maggots Rid Patients of MRSA 2Health News:Vaccine Prevents Prion Disease in Mice 2Health News:Cause of Gender Differences in Blood Pressure, Kidney Damage Under Study 2Health News:Cause of Gender Differences in Blood Pressure, Kidney Damage Under Study 3
McIntyre-Binkhorst Cannula have a smooth blunt tip end opening....
Army navy retractor set....
Sharp. 4 mm wide. Hand-Held...
Adsons bayonet forceps....
Medicine Products: